Sittner & Nelson’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.39K Hold
400
﹤0.01% 512
2026
Q1
$2.18K Hold
400
﹤0.01% 511
2025
Q4
$2K Hold
400
﹤0.01% 481
2025
Q3
$3.09K Hold
400
﹤0.01% 426
2025
Q2
$3.48K Hold
400
﹤0.01% 426
2025
Q1
$3.18K Hold
400
﹤0.01% 419
2024
Q4
$3.64K Sell
400
-40
-9% -$386 ﹤0.01% 396
2024
Q3
$4.04K Hold
440
﹤0.01% 384
2024
Q2
$4.3K Hold
440
﹤0.01% 392
2024
Q1
$6.64K Hold
440
﹤0.01% 374
2023
Q4
$9.48K Sell
440
-40
-8% -$738 0.01% 347
2023
Q3
$8.92K Buy
480
+40
+9% +$934 0.01% 348
2023
Q2
$11.1K Sell
440
-35
-7% -$881 0.01% 335
2023
Q1
$12.3K Buy
475
+40
+9% +$1.07K 0.01% 348
2022
Q4
$10.3K Hold
435
0.01% 338
2022
Q3
$11K Hold
435
0.01% 325
2022
Q2
$14K Hold
435
0.01% 328
2022
Q1
$31K Hold
435
0.02% 240
2021
Q4
$40K Hold
435
0.02% 221
2021
Q3
$55K Sell
435
-70
-14% -$10.2K 0.04% 185
2021
Q2
$84K Buy
505
+60
+13% +$9.72K 0.06% 140
2021
Q1
$81K Buy
445
+45
+11% +$10.4K 0.06% 142
2020
Q4
$80K Buy
+400
New +$81.3K 0.07% 130

Other funds holding TDOC

Sittner & Nelson's TDOC Position: Q2 2026 in Review

Sittner & Nelson held its Teladoc Health (TDOC) position steady in Q2 2026 at 400 shares worth $3.39K. The position accounts for ﹤0.01% of the portfolio, ranked #512.

Sittner & Nelson first reported a position in TDOC in Q4 2020 and has held it in 23 quarters since. The position peaked at $84K in Q2 2021. 348 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

  • Sittner & Nelson held 400 shares of Teladoc Health worth $3.39K as of Q2 2026.
  • Sittner & Nelson left its Teladoc Health share count unchanged in Q2 2026.
  • Teladoc Health made up ﹤0.01% of Sittner & Nelson's portfolio in Q2 2026, its #512 holding.
  • Sittner & Nelson first reported a position in Teladoc Health in Q4 2020 and has held it in 23 quarters since.
  • Sittner & Nelson's Teladoc Health position peaked at $84K in Q2 2021.
  • 348 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on Sittner & Nelson's 13F filing for Q2 2026, filed 7 Aug 2026.